Search results for: Precision Medicine
Filter search results
Personalised Medicine and the Value of Molecular Diagnostics: Case Studies
18 December 2013
…open-access publication, OHE’s Adrian Towse and his co-authors examine nine case studies of diagnostics that have been successful in advancing personalised medicine. Progress in personalised medicine is slower than some…
Recently Published: New Report Comparing Usage of Medicines in the UK with Other Countries
6 January 2015
…of medicines in the UK relative to 12 comparable high-income countries including France, Germany, Italy, Spain and the USA. Sixteen classes of medicines were included in the original Richards report…
The Impact of New Medicines in the NHS: 70 Years of Innovation
14 August 2018
…medicines in terms of health and economic outcomes. Our interviews with experts identified a shortlist of ten important new medicines introduced in the NHS in the last 70 years, which…
The Impact of New Medicines in the NHS: 70 Years of Innovation
1 August 2018
…from new medicines. Their role should be considered in the use of medicines in the NHS over the next 70 years and for new medicines currently in the development pipeline….
Projecting Expenditure on Medicines in the NHS
4 January 2013
…scrutiny in efforts to manage costs. Forecasting spending on medicines can be useful… Medicines account for less than 10% of total NHS expenditure in the UK. Because spending on medicines…
Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
1 December 2017
…and made mandatory for orphan and oncology medicines. We analysed routine funding in the NHS for new medicines recently authorised via the centralised procedure with a particular focus on oncology…
NGS testing for lung cancer across Europe still limited, despite clear case for adoption
10 July 2023
…more personalised cancer care,” said Professor Mike Drummond, University of York. “As new precision therapies become available, the importance of NGS will increase, and the cost-effectiveness of these therapies will…
Grow and diversify funding for prevention to boost the nation’s health and prosperity, urges landmark report
12 October 2023
…of optimised prevention: Long-term cross-party agreement. Innovative financing of prevention within NHS budgets. Financing prevention outside core NHS budgets. Improved monitoring. Embracing new opportunities, including precision medicine and digital health….
Katherine Payne
30 January 2024
Katherine was awarded a personal chair in health economics at The University of Manchester in August 2010. Katherine’s interest in the economics of precision medicine and genomics technologies and services…